ResultsMoneycontrol
Gland Pharma shares rally 8% to hit 4-year-high post strong Q2
Positive+43Company event
GreyOak summary
Gland Pharma shares rose 8% to a four-year high after reporting a 58.29% jump in net profit to Rs 290.75 crore in Q2 FY27. Revenue grew to Rs 1,833.58 crore driven by strong execution in European and US markets. Brokerages remain divided, with Motilal Oswal maintaining a Buy rating while Elara Capital downgraded to Sell.
What it affects
- Gland PharmaGLANDPositive +43
Shares rallied 8% to a 4-year highRolling sentiment Positive +64
Source
Read the original at MoneycontrolMore Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divis, Gland, Sai Life Sciences shares hit 52-week highsBusiness Today · Stock view ·
- Gland Pharma shares jump 4% as Q2 profit jumps 58%Economic Times · Results ·